Recalls

FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring (CGM)  – 11/26/2025
 
A voluntary recall initiated by Abbott, the manufacturer of the FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) systems. Abbott has identified that certain sensors may provide inaccurate low glucose readings, which could lead to inappropriate treatment decisions. In rare cases, affected sensors may also pose a battery-related safety risk, including overheating or device malfunction. We want to emphasize that not all sensors are affected—only those from specific lot numbers identified by Abbott.
 
View our full release at, https://loom.ly/MGf_ndg

 

Prazosin hydrochloride capsules – 10/24/2025

The FDA published a Class II recall for prazosin hydrochloride manufactured by Teva Pharmaceuticals. A Class II recall indicates that use of or exposure to the product “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” The recall affects three dosage strengths and multiple lot numbers that contained potentially cancer-causing chemicals above acceptable safety limits.

 

Yellowhawk pharmacy has not purchased or dispensed any of the affected lots of prazosin hydrochloride and patients receiving this drug from Yellowhawk pharmacy are not affected by this drug recall.

View more information here.

Duloxetine delayed-release capsules – 10/10/2024

The FDA published a patient level recall of duloxetine delayed-release 20mg capsules manufactured by Breckenridge Pharmaceutical, Inc. Yellowhawk pharmacy has not purchased or dispensed the affected lot (Lot #: 220128, Expiration date: 12/2024). Patients receiving Duloxetine from Yellowhawk pharmacy are not affected by this drug recall. View more information here.

View more information here.

Artificial Tears Lubricant Eye Drops – 10/31/2023

Last week the FDA issued a warning about the following brands of artificial tears due to a risk of eye infection: CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up & Up, and Velocity Pharma. On 10.30, the Walmart Equate brand was also added (see release and more information at the link below).
 
At this time, there have been no known adverse effects (eye infections) reported. This is a precautionary move after discovering potential bacterial contamination at the manufacturing facility. If you use artificial tears (non-medicated lubricating eye drops) for dry eye, it is recommended that you check the brand before further use. Throw them away if they are one of the listed brands on the FDA site. This recall does not include all artificial tears – continue using other brands of artificial tears once you have determined they are not on the FDA recall list. Yellowhawk dispenses the Refresh brand artificial tears through Yellowhawk’s pharmacy. Patients who received drops from our pharmacy are okay to continue using as directed by your eye doctor, if you are unsure, please give your provider a call. If you have concerns about the brand of drops you are using, please stop using and call Yellowhawk Optometry at 541.240.8759 or stop by the Yellowhawk Optometry desk from 8 am-12 pm or 1-4 pm.

View more information here.

Artificial Tears Lubricant Eye Drops – 02/02/2023

Global Pharma Healthcare is voluntarily recalling all lots of their Artificial Tears Lubricant Eye Drops, distributed by EzriCare & Delsam Pharma, to the consumer level, due to possible contamination. Yellowhawk pharmacy has not purchased nor dispensed any artificial tear products from these distributors. Patients receiving Artificial Tears from Yellowhawk pharmacy are not affected by this drug recall.

View more information here.

Irbesartan and irbesartan/hydrochlorothiazide – 10/12/2021

The FDA published a patient level recall of irbesartan and irbesartan-hydrochlorothiazide combination tablets manufactured by Lupin. Yellowhawk pharmacy has not purchased or dispensed Lupin brand tablets in 2021. Patients receiving Irbesartan from Yellowhawk pharmacy are not affected by this drug recall.

View more information here.

 

Chantix (Varenicline) – 09/17/2021

The FDA published an updated recalled Chantix (Varenicline) list. Patients with supplies of Chantix (Varenicline) should contact Yellowhawk pharmacy at (541)240-8691.

View more information here.

 

 

Metformin – 10/5/2020

The FDA published an updated recalled metformin list. Patients taking metformin should contact their doctor and or pharmacist for replacement or different treatment option.